WO2010047826A3 - Dosing regimens and dosage formulations of an antiviral peptide therapeutic - Google Patents

Dosing regimens and dosage formulations of an antiviral peptide therapeutic Download PDF

Info

Publication number
WO2010047826A3
WO2010047826A3 PCT/US2009/005781 US2009005781W WO2010047826A3 WO 2010047826 A3 WO2010047826 A3 WO 2010047826A3 US 2009005781 W US2009005781 W US 2009005781W WO 2010047826 A3 WO2010047826 A3 WO 2010047826A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosing regimens
dosage formulations
peptide therapeutic
antiviral peptide
antiviral
Prior art date
Application number
PCT/US2009/005781
Other languages
French (fr)
Other versions
WO2010047826A2 (en
Inventor
Brian L. Bray
Jie Di
Michael Greenberg
David Heilman
Carol Ohmstede
Peter Silinski
Scott Webb
Original Assignee
Trimeris, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trimeris, Inc. filed Critical Trimeris, Inc.
Publication of WO2010047826A2 publication Critical patent/WO2010047826A2/en
Publication of WO2010047826A3 publication Critical patent/WO2010047826A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus

Abstract

Provided herein are dosage formulations and dosing regimens of an antiviral peptide therapeutic, including methods of using the same.
PCT/US2009/005781 2008-10-24 2009-10-23 Dosing regimens and dosage formulations of an antiviral peptide therapeutic WO2010047826A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10804808P 2008-10-24 2008-10-24
US61/108,048 2008-10-24

Publications (2)

Publication Number Publication Date
WO2010047826A2 WO2010047826A2 (en) 2010-04-29
WO2010047826A3 true WO2010047826A3 (en) 2011-06-09

Family

ID=42040258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/005781 WO2010047826A2 (en) 2008-10-24 2009-10-23 Dosing regimens and dosage formulations of an antiviral peptide therapeutic

Country Status (1)

Country Link
WO (1) WO2010047826A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11667678B2 (en) 2019-04-21 2023-06-06 Rush University Medical Center Peptides for the treatment of COVID-19
US11339190B2 (en) 2020-04-21 2022-05-24 Rush University Medical Center Peptides for the treatment of covid-19

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037896A2 (en) * 1999-07-09 2001-05-31 Trimeris, Inc. Methods and compositions for administration of therapeutic reagents
US20070179278A1 (en) * 2006-02-02 2007-08-02 Trimeris, Inc. HIV fusion inhibitor peptides with improved biological properties
WO2008124013A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037896A2 (en) * 1999-07-09 2001-05-31 Trimeris, Inc. Methods and compositions for administration of therapeutic reagents
US20070179278A1 (en) * 2006-02-02 2007-08-02 Trimeris, Inc. HIV fusion inhibitor peptides with improved biological properties
WO2008124013A1 (en) * 2007-04-03 2008-10-16 Trimeris, Inc. Novel formulations for delivery of antiviral peptide therapeutics

Also Published As

Publication number Publication date
WO2010047826A2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
HK1211463A1 (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
SI2069342T1 (en) 2-ARYL-6-PHENYLIMIDAZO?á1,2-A?åPYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
CL2007002017A1 (en) COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
WO2011088120A8 (en) Antibody formulation and therapeutic regimens
WO2007100901A3 (en) Epinephrine dosing regimens
TN2011000172A1 (en) Therapeutic antiviral peptides
CL2007000161A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED 2,4-DIOXOIMIDAZOLIDINE, INHIBITORS OF KINE PROTEINS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER.
WO2010021607A3 (en) Pharmaceutical formulation
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
BR112012003800A2 (en) composition, peptide, and pharmaceutical formulation.
FR2915199B1 (en) TRIAZOLOPYRIDINE-CARBOXAMIDE AND TRIAZOLOPYRIMIDINE-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
TW200942530A (en) Pyridine compounds
IL220894A (en) Active ingredient combinations comprising dihydrofuranone derivatives and abamectin, mixture/beneficial species combinations and kit comprising same and uses thereof
WO2009099467A3 (en) Cyclosporin compositions
MX2009010689A (en) Novel formulations for delivery of antiviral peptide therapeutics.
EP2261221A4 (en) Epothilone analogues, their pharmaceutical compositions, their use and their preparations
IL211670A0 (en) Therapeutic protein formulations
ZA201009097B (en) C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
BRPI0910570A2 (en) use of bioconjugates and pharmaceutical formulations
WO2009156071A8 (en) Combination of amidine derivates with cyclic depsipeptides
WO2009042194A3 (en) Methods of synthesis for therapeuthic anti-hiv peptides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09744234

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09744234

Country of ref document: EP

Kind code of ref document: A2